Sara Cannon Research Institution (SCRI) - Tennessee Oncology Nashville — Nashville, Tennessee

Sara Cannon Research Institution (SCRI) - Tennessee Oncology Nashville is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Sara Cannon Research Institution (SCRI) - Tennessee Oncology Nashville has participated in 1 clinical trials.

Therapeutic areas: Advanced/Metastatic Solid Tumor.

Sponsors: Kezar Life Sciences, Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sara Cannon Research Institution (SCRI) - Tennessee Oncology Nashville?

Sara Cannon Research Institution (SCRI) - Tennessee Oncology Nashville has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sara Cannon Research Institution (SCRI) - Tennessee Oncology Nashville conducted?

Sara Cannon Research Institution (SCRI) - Tennessee Oncology Nashville has 1 clinical trials on record. Their work covers Advanced/Metastatic Solid Tumor.

Is Sara Cannon Research Institution (SCRI) - Tennessee Oncology Nashville accredited by Crixeo Health?

Sara Cannon Research Institution (SCRI) - Tennessee Oncology Nashville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sara Cannon Research Institution (SCRI) - Tennessee Oncology Nashville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.